James R. Tobin

James R. Tobin (board member) discloses dealings in 2 companies, chiefly TransMedics Group, Inc. and Globus Medical Inc. In total, 21 filings cover trades dated from 10 May 2021 to 15 September 2026.

Sales make up the whole of the open-market record (10 sales, €11.8M). Outside the open market, there are 3 share grants and 5 option exercises. So far in 2026, the count stands at no purchases and 1 sale.

On 16 September 2026 came the latest disclosure, an option exercise for €699k in Globus Medical Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.